BioLight Life Sciences Ltd - Asset Resilience Ratio

Latest as of December 2025: 46.39%

BioLight Life Sciences Ltd (BOLT) has an Asset Resilience Ratio of 46.39% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read BioLight Life Sciences Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

ILA19.68 Million

≈ $52.75K USD Cash + Short-term Investments

Total Assets

ILA42.41 Million

≈ $113.71K USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how BioLight Life Sciences Ltd's Asset Resilience Ratio has changed over time. See BioLight Life Sciences Ltd book value and equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down BioLight Life Sciences Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of BioLight Life Sciences Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	ILA0.00	0%
Short-term Investments	ILA19.68 Million	46.39%
Total Liquid Assets	ILA19.68 Million	46.39%

Asset Resilience Insights

Very High Liquidity: BioLight Life Sciences Ltd maintains exceptional liquid asset reserves at 46.39% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

BioLight Life Sciences Ltd Industry Peers by Asset Resilience Ratio

Compare BioLight Life Sciences Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sagimet Biosciences Inc. Series A Common Stock NASDAQ:SGMT	Biotechnology	63.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
Inner Mongolia Furui Med Sci SHE:300049	Biotechnology	2.34%
Bio-Thera Solutions Ltd SHG:688177	Biotechnology	4.09%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Gubra A/S CO:GUBRA	Biotechnology	79.61%

Annual Asset Resilience Ratio for BioLight Life Sciences Ltd (2005–2025)

The table below shows the annual Asset Resilience Ratio data for BioLight Life Sciences Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	46.39%	ILA19.68 Million ≈ $52.75K	ILA42.41 Million ≈ $113.71K	+35.40pp
2024-12-31	10.99%	ILA3.75 Million ≈ $10.06K	ILA34.12 Million ≈ $91.48K	+10.25pp
2023-12-31	0.75%	ILA250.00K ≈ $670.24	ILA33.45 Million ≈ $89.68K	-6.68pp
2022-12-31	7.42%	ILA4.23 Million ≈ $11.35K	ILA57.01 Million ≈ $152.84K	+7.04pp
2021-12-31	0.38%	ILA245.00K ≈ $656.84	ILA64.17 Million ≈ $172.04K	-30.41pp
2020-12-31	30.79%	ILA19.96 Million ≈ $53.51K	ILA64.83 Million ≈ $173.80K	+24.65pp
2019-12-31	6.14%	ILA4.60 Million ≈ $12.34K	ILA74.95 Million ≈ $200.94K	+5.71pp
2018-12-31	0.43%	ILA387.00K ≈ $1.04K	ILA90.28 Million ≈ $242.04K	-1.24pp
2017-12-31	1.66%	ILA412.00K ≈ $1.10K	ILA24.76 Million ≈ $66.39K	+0.48pp
2016-12-31	1.18%	ILA417.00K ≈ $1.12K	ILA35.31 Million ≈ $94.67K	+0.57pp
2015-12-31	0.61%	ILA385.00K ≈ $1.03K	ILA63.27 Million ≈ $169.63K	-15.24pp
2014-12-31	15.85%	ILA6.41 Million ≈ $17.18K	ILA40.43 Million ≈ $108.40K	+15.31pp
2013-12-31	0.54%	ILA185.00K ≈ $495.98	ILA34.33 Million ≈ $92.04K	-0.92pp
2012-12-31	1.46%	ILA610.00K ≈ $1.64K	ILA41.89 Million ≈ $112.31K	-22.26pp
2011-12-31	23.72%	ILA7.03 Million ≈ $18.84K	ILA29.63 Million ≈ $79.44K	+2.44pp
2010-12-31	21.28%	ILA2.16 Million ≈ $5.79K	ILA10.14 Million ≈ $27.18K	-27.61pp
2009-12-31	48.90%	ILA11.00 Million ≈ $29.48K	ILA22.49 Million ≈ $60.29K	-31.56pp
2006-12-31	80.46%	ILA38.75 Million ≈ $103.89K	ILA48.16 Million ≈ $129.12K	-4.55pp
2005-12-31	85.01%	ILA17.33 Million ≈ $46.47K	ILA20.39 Million ≈ $54.66K	--

pp = percentage points

About BioLight Life Sciences Ltd

TA:BOLT Israel Biotechnology

Market Cap

$7.66 Million

ILA2.86 Billion ILA

Market Cap Rank

#27662 Global

#402 in Israel

Share Price

ILA315.60

Change (1 day)

+1.06%

52-Week Range

ILA217.90 - ILA604.90

All Time High

ILA3485.66